Sector: Biotech
Platform: StartEngine
Stage: R&D
Minimum Investment: $500
🧩 What They Do
Foment Bio is pioneering a new approach to regenerative medicine using transient gene therapy—a method designed to activate the body’s own repair mechanisms without permanent genetic modification. Their platform aims to heal tissues and organs more safely and effectively than traditional gene therapy.
📈 Why It Might Be the Next Big Thing
Transient gene therapy could offer the benefits of genetic medicine without long-term risks
Regenerative medicine is a $38B+ market growing fast
Addresses conditions ranging from aging to injury recovery
Appeals to both longevity investors and biotech futurists
📌 Snapshot
💵 Min. Investment: $500
📊 Growth Signal: Positioned at the forefront of next-gen gene therapy
🧠 Founder Cred: Backed by scientific research and medical innovation
🔎 My Take
Foment Bio is going after one of biotech’s biggest frontiers—repairing the body using our own biological programming. It’s early-stage science, but if they pull this off, the potential is game-changing. For deep-tech biotech believers, this could be a sleeper hit.